Turmeric (Haridra): Plant Profile, Traditional Use, and Modern Research
The 30-second answer
Turmeric is the bright-orange rhizome of Curcuma longa, a perennial plant in the Zingiberaceae (ginger) family. It has been used in Ayurvedic medicine for over 4,000 years and as a culinary spice for at least as long. Its dominant active compound, curcumin, has been studied in over a hundred clinical trials and is one of the most researched plant compounds in the world. Curcumin’s natural bioavailability is poor – a problem solved by the traditional Ayurvedic and South Asian practice of pairing turmeric with black pepper, which contains piperine. As a food supplement in the UK, turmeric is regulated under food law, not as a medicine.
Key facts
- Plant family: Zingiberaceae (ginger family)
- Part used: rhizome (the underground stem, often called “root”)
- Active compounds: curcuminoids (curcumin, demethoxycurcumin, bisdemethoxycurcumin), turmerones, polysaccharides
- Bioavailability: poor on its own; piperine (from black pepper) raises curcumin bioavailability dramatically
- Traditional context: kapha-vata pacifying, classical “golden” herb
- Doses studied: 500mg–2,000mg curcumin daily, often with piperine, 4–12 weeks
- Should not use: gallstones, bile duct obstruction, anticoagulant medication (without GP guidance), iron-deficiency anaemia
What is turmeric?
Turmeric is one of the most recognisable herbs in the world – the bright-orange spice that gives curry its colour, the warming powder in golden milk, and the subject of more clinical trials than almost any other plant. Its botanical name is Curcuma longa, and it belongs to the Zingiberaceae family – the ginger family – which is why turmeric and ginger have a similar earthy, pungent quality.
The plant grows up to a metre tall, with broad leaves emerging from rhizomes (underground stems) that branch and thicken below ground. The rhizomes are the medicinal part, and their distinctive deep-orange interior comes from a single class of compounds: the curcuminoids. The Sanskrit name haridra means “yellow one” – a name shared with the colour of saffron and gold, both considered auspicious in Indian tradition.
The rhizome is the medicinal part.
Which parts of the plant are used?
The rhizome is the only medicinal part used in modern supplements and clinical research. Although commonly called “root,” the rhizome is technically a horizontal underground stem, and it is from this part that the spice and the supplement are derived. Rhizomes are typically harvested 8 to 10 months after planting, then boiled, sun-dried, and either ground into powder or processed into curcumin extract.
The leaves are used in some traditional South Asian cooking but are not typically used in supplements. The fresh rhizome is sometimes available in Indian and Asian grocers and is the form closest to traditional Ayurvedic preparations.
Did you know?
Curcumin only makes up about 2–8% of dried turmeric powder by weight. The rest is starches, fibre, volatile oils, and other minor compounds. This is why most clinical trials use standardised curcumin extracts (typically 95% curcuminoids), not raw turmeric powder.
Active compounds
Turmeric’s active compounds fall into two main categories. The curcuminoids are the dominant group: curcumin itself, alongside demethoxycurcumin and bisdemethoxycurcumin. These are polyphenolic pigments responsible for the rhizome’s colour and the majority of its measured biological activity. Curcumin is by far the most studied of the three.
The turmerones – ar-turmerone, alpha-turmerone, beta-turmerone – make up the volatile oil fraction and contribute the herb’s aroma and warming character. They have been studied for distinct pharmacological properties beyond those of the curcuminoids.
Turmeric also contains polysaccharides, proteins, and a small amount of essential minerals. Most modern standardised extracts are characterised by their curcuminoid content, with 95% curcuminoids being the most common research-grade specification.
4,000+
Years of use
100+
Clinical trials
~2,000%
Bioavailability boost
The bioavailability problem (and why black pepper)
Curcumin has a stubborn problem: most of it doesn’t reach the bloodstream. When taken alone, oral curcumin is poorly absorbed in the gut, rapidly metabolised by the liver, and excreted before it can act. Plasma levels in early human studies were so low that some researchers questioned whether oral curcumin could have any meaningful systemic effect at all.
The traditional solution turns out to be the right one. Ayurvedic and South Asian cooking has paired turmeric with black pepper for thousands of years – in curry powders, in golden milk, in everyday daal. Black pepper contains piperine, an alkaloid that inhibits the liver enzymes responsible for clearing curcumin. The result: piperine doesn’t make curcumin more absorbable per se, but it dramatically slows its metabolism, so plasma levels rise.
The landmark study is Shoba et al. (1998, Planta Medica), which compared curcumin alone to curcumin combined with 20mg of piperine in healthy human volunteers. The piperine-paired group showed roughly a 2,000% (twentyfold) increase in curcumin bioavailability. Subsequent research has explored other bioavailability-enhancing approaches – phospholipid complexes (such as the Meriva extract), liposomal formulations, and nanoparticle preparations – but the simple turmeric-and-black-pepper combination remains the most widely used and the most traditional.
The traditional kitchen pairing of turmeric and black pepper, used for centuries in Indian cooking, turned out to be a bioavailability hack.
— a paraphrase of the broad consensus across modern bioavailability research
A brief history of turmeric
c. 2000 BCE – 600 CE
Vedic and classical period
Turmeric is one of the oldest cultivated plants in the world. Archaeological evidence places its domestication in South Asia as early as 2,000 BCE. It appears in the Atharva Veda and is described in detail in the Charaka Samhita and the Sushruta Samhita, classified for its warming, drying qualities and used in formulations for skin, joints, and digestion.
c. 600 – 1700 CE
Medieval Ayurvedic and global spread
The Bhavaprakasha described turmeric in granular detail and listed dozens of formulations. By this period turmeric had spread along trade routes to East Asia, the Middle East, and parts of Europe. It became central to South Indian, Persian, and later European culinary traditions.
1700s – 1947
Colonial era
British colonial physicians and botanists encountered turmeric ubiquitously in Indian kitchens and Ayurvedic clinics. It was catalogued in colonial flora, sometimes used as a dye for fabrics, and described in early Western herbal materia medica. Pharmacological investigation, however, remained minimal.
1815 – 1990s
Curcumin chemistry
Curcumin was first isolated in 1815 by Vogel and Pelletier in France. Its full chemical structure was determined by 1910. Indian researchers, particularly at the Central Drug Research Institute in Lucknow, drove much of the 20th-century pharmacological investigation. Shoba et al.’s landmark 1998 piperine bioavailability study transformed how curcumin was formulated for clinical research.
2000s – present
The clinical trial era
Curcumin has been the subject of an extraordinary surge of clinical research from the early 2000s onward, with over 100 published human trials and several major meta-analyses. It is now one of the most studied plant compounds in the world.
Traditional Ayurvedic context
In classical Ayurveda, turmeric is described as bitter, pungent, light, dry, and warming. It primarily balances kapha and vata doshas. Classical texts describe traditional applications including topical preparations for the skin, internal preparations for joints and digestion, and use in classical pre-wedding ceremonies (the haldi ceremony).
Traditional Ayurvedic descriptions of turmeric’s role include classical golden-milk preparations (haldi doodh) combining turmeric, milk, ghee, and black pepper, topical pastes traditionally used for skin and minor joint contexts, classical formulations for digestive sluggishness, and ceremonial use in pre-wedding traditions across South Asia. These descriptions reflect classical Ayurvedic categorisation and historical use; they do not constitute claims about the effects of any modern food supplement.
Modern research
Curcumin has one of the largest clinical evidence bases of any plant-derived compound, with research spanning joint and inflammation endpoints, cardiovascular markers, cognitive endpoints, mood, glycaemic markers, and skin. The studies described below are reported here as published research; the descriptions are not statements about the effects of any r‑veda product.
| Topic | Study | Participants | Duration |
|---|---|---|---|
| Bioavailability | Shoba 1998 | Healthy volunteers | Acute |
| Joint markers | Kuptniratsaikul 2014 | 367 | 4 weeks |
| Joint markers (meta) | Daily 2016 | 8 trials pooled | – |
| Lipid markers (meta) | Sahebkar 2015 | 7 trials pooled | – |
| Cognition (older adults) | Small 2018 | 40 | 18 months |
| Mood | Sanmukhani 2014 | 60 | 6 weeks |
| Cognitive (acute) | Cox 2015 | 60 | 4 weeks |
| Joint markers | Madhu 2013 | 120 | 42 days |
Tap a column heading to sort. Scroll for the full table on small screens.
See full study details
Joint and inflammation research
Kuptniratsaikul et al. (2014, Clinical Interventions in Aging) studied 367 adults over four weeks comparing 1,500mg/day of standardised curcumin extract against ibuprofen, with joint pain and function as primary endpoints. Daily, Yang, and Park (2016, Journal of Medicinal Food) conducted a meta-analysis pooling eight randomised controlled trials on curcumin in osteoarthritis. Madhu et al. (2013, Inflammopharmacology) studied 120 participants over 42 days using curcumin combined with phospholipid carriers.
Cardiovascular research
Sahebkar et al. (2015, Phytotherapy Research) ran a meta-analysis of seven randomised controlled trials on curcumin and lipid markers, pooling data on total cholesterol, LDL, HDL, and triglycerides. Multiple subsequent meta-analyses have replicated similar measurement patterns.
Cognitive research
Small et al. (2018, American Journal of Geriatric Psychiatry) studied 40 older adults given 90mg of bioavailable curcumin twice daily for 18 months, with cognitive performance and brain amyloid imaging as endpoints. Cox et al. (2015, Journal of Psychopharmacology) studied 60 healthy adults given a bioavailable curcumin formulation over four weeks, measuring acute and longer-term cognitive performance.
Mood research
Sanmukhani et al. (2014, Phytotherapy Research) studied 60 participants over six weeks comparing curcumin to fluoxetine and a combination of both, measuring depression scale scores. Multiple subsequent trials have measured mood-related endpoints with curcumin or curcumin-piperine combinations.
Bioavailability research
Shoba et al. (1998, Planta Medica) is the foundational study showing piperine increased curcumin bioavailability by approximately 2,000% in healthy human volunteers. Subsequent research has extended this to phospholipid complexes (Marczylo 2007), liposomal formulations, and nanoparticle preparations, all aimed at the same fundamental challenge.
How to read this evidence base
Curcumin has more clinical research than almost any other Ayurvedic compound. Trials are still mostly small to moderate in size (60–400 participants), but there are now several solid meta-analyses across multiple endpoints. The biggest practical caveat is bioavailability: studies using plain curcumin without piperine, phospholipids, or nanoparticle delivery often show smaller effects, and direct comparisons between formulations are still limited. When evaluating turmeric supplements, the bioavailability strategy matters at least as much as the curcumin dose.
Forms and preparations
Turmeric has been consumed in many forms across history.
- Culinary spice–dried rhizome powder used in cooking; the everyday form, very low curcumin dose
- Golden milk (haldi doodh)–traditional preparation combining turmeric, milk, ghee, and black pepper
- Fresh rhizome–grated or juiced; closer to traditional Ayurvedic preparations
- Standardised curcumin extract–concentrated form used in clinical trials, typically 95% curcuminoids, paired with piperine or another bioavailability enhancer
- Capsule–the most dose-accurate option for daily use, almost always combining curcumin with piperine
Doses used in clinical research range from 500mg to 2,000mg of curcuminoids per day, almost always paired with bioavailability enhancers such as piperine. Effective study durations are typically 4 to 12 weeks. These figures describe what has been studied in research – they are not dietary recommendations.
Suitability and cautions
Turmeric is generally well tolerated at culinary doses. At supplemental doses, several cautions apply:
- People with gallstones, bile duct obstruction, or significant gallbladder dysfunction should avoid supplemental turmeric.
- People taking warfarin or other anticoagulants should consult a GP before use; curcumin may have mild blood-thinning effects.
- People with iron-deficiency anaemia should be aware that curcumin can bind iron and reduce its absorption; consult a GP.
- People taking medications metabolised by liver enzymes (a wide group, including some statins, diabetes medications, and chemotherapy agents) should consult a GP – piperine is a known modulator of these enzymes.
- Pregnant or breastfeeding women should consult a healthcare practitioner before supplemental use; culinary turmeric is generally considered fine.
- High-dose curcumin can cause mild gastric upset in sensitive individuals.
As with any food supplement, stop use and consult a healthcare professional if you experience any adverse effects.
